Efficacy of Lactobacillus reuteri PBS072 and Bifidobacterium breve BB077 in the prevention and treatment of work-related stress symptoms: a cross-over randomized trial

niversity of Calabria0 个研究点目标入组 33 人开始时间: 2021年4月29日最近更新: 2023年6月26日

试验速览

2023 Results article in https://doi.org/10.1159/000527956 (added 12/06/2023)

•1. Adults aged between 18 and 65 in good health
•2. Willing to use only the products to be tested throughout the study period
•3. Willing not to use similar products that could interfere with the product to be tested
•4. Willing not to change normal daily routine (e.g. lifestyle, physical activity, etc)

•1. Subjects with known or suspected sensitization to one or more ingredients of the formulation in question
•2. Subjects unable to communicate or collaborate with the investigator due to language problems, intellectual disability, or impaired brain function
•3. People suffering from psychiatric disorders such as schizophrenia, or psychotic disorders such as bipolar disorder or substance use disorder
•4. Use of herbal remedies or psychotropic drugs intended for depression taken in the last 2 weeks before baseline or during the study
•5. Receive counseling or psychological therapy at the beginning or during the study
•6. Participation in any clinical trial in the previous 3 months prior to baseline
•7. Subjects who plan to take antibiotics during the treatment period

发起方

niversity of Calabria